123 related articles for article (PubMed ID: 20690686)
1. Synthesis, in vitro activity, and three-dimensional quantitative structure-activity relationship of novel hydrazine inhibitors of human vascular adhesion protein-1.
Nurminen EM; Pihlavisto M; Lázár L; Szakonyi Z; Pentikäinen U; Fülöp F; Pentikäinen OT
J Med Chem; 2010 Sep; 53(17):6301-15. PubMed ID: 20690686
[TBL] [Abstract][Full Text] [Related]
2. Novel hydrazine molecules as tools to understand the flexibility of vascular adhesion protein-1 ligand-binding site: toward more selective inhibitors.
Nurminen EM; Pihlavisto M; Lázár L; Pentikäinen U; Fülöp F; Pentikäinen OT
J Med Chem; 2011 Apr; 54(7):2143-54. PubMed ID: 21405023
[TBL] [Abstract][Full Text] [Related]
3. A peptide inhibitor of vascular adhesion protein-1 (VAP-1) blocks leukocyte-endothelium interactions under shear stress.
Yegutkin GG; Salminen T; Koskinen K; Kurtis C; McPherson MJ; Jalkanen S; Salmi M
Eur J Immunol; 2004 Aug; 34(8):2276-85. PubMed ID: 15259025
[TBL] [Abstract][Full Text] [Related]
4. Identification of two imidazole binding sites and key residues for substrate specificity in human primary amine oxidase AOC3.
Elovaara H; Kidron H; Parkash V; Nymalm Y; Bligt E; Ollikka P; Smith DJ; Pihlavisto M; Salmi M; Jalkanen S; Salminen TA
Biochemistry; 2011 Jun; 50(24):5507-20. PubMed ID: 21585208
[TBL] [Abstract][Full Text] [Related]
5. Structure of human semicarbazide-sensitive amine oxidase/vascular adhesion protein-1.
Jakobsson E; Nilsson J; Ogg D; Kleywegt GJ
Acta Crystallogr D Biol Crystallogr; 2005 Nov; 61(Pt 11):1550-62. PubMed ID: 16239734
[TBL] [Abstract][Full Text] [Related]
6. A structure-activity study to identify novel and efficient substrates of the human semicarbazide-sensitive amine oxidase/VAP-1 enzyme.
Bonaiuto E; Lunelli M; Scarpa M; Vettor R; Milan G; Di Paolo ML
Biochimie; 2010 Jul; 92(7):858-68. PubMed ID: 20298739
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity.
Wang EY; Gao H; Salter-Cid L; Zhang J; Huang L; Podar EM; Miller A; Zhao J; O'rourke A; Linnik MD
J Med Chem; 2006 Apr; 49(7):2166-73. PubMed ID: 16570912
[TBL] [Abstract][Full Text] [Related]
8. New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking.
Yraola F; García-Vicente S; Fernandez-Recio J; Albericio F; Zorzano A; Marti L; Royo M
J Med Chem; 2006 Oct; 49(21):6197-208. PubMed ID: 17034126
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase.
Salter-Cid LM; Wang E; O'Rourke AM; Miller A; Gao H; Huang L; Garcia A; Linnik MD
J Pharmacol Exp Ther; 2005 Nov; 315(2):553-62. PubMed ID: 16081681
[TBL] [Abstract][Full Text] [Related]
10. Cloning and characterization of mouse vascular adhesion protein-1 reveals a novel molecule with enzymatic activity.
Bono P; Salmi M; Smith DJ; Jalkanen S
J Immunol; 1998 Jun; 160(11):5563-71. PubMed ID: 9605161
[TBL] [Abstract][Full Text] [Related]
11. Function-blocking antibodies to human vascular adhesion protein-1: a potential anti-inflammatory therapy.
Kirton CM; Laukkanen ML; Nieminen A; Merinen M; Stolen CM; Armour K; Smith DJ; Salmi M; Jalkanen S; Clark MR
Eur J Immunol; 2005 Nov; 35(11):3119-30. PubMed ID: 16224816
[TBL] [Abstract][Full Text] [Related]
12. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1: a patent survey.
Dunkel P; Balogh B; Meleddu R; Maccioni E; Gyires K; Mátyus P
Expert Opin Ther Pat; 2011 Sep; 21(9):1453-71. PubMed ID: 21675926
[TBL] [Abstract][Full Text] [Related]
13. The discovery and development of selective 3-fluoro-4-aryloxyallylamine inhibitors of the amine oxidase activity of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1).
Foot JS; Deodhar M; Turner CI; Yin P; van Dam EM; Silva DG; Olivieri A; Holt A; McDonald IA
Bioorg Med Chem Lett; 2012 Jun; 22(12):3935-40. PubMed ID: 22595173
[TBL] [Abstract][Full Text] [Related]
14. Synthetic polyamines as potential amine oxidase inhibitors: a preliminary study.
Emanuela B; Minarini A; Tumiatti V; Milelli A; Lunelli M; Pegoraro M; Rizzoli V; Di Paolo ML
Amino Acids; 2012 Feb; 42(2-3):913-28. PubMed ID: 21858471
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema: part 2.
Inoue T; Morita M; Tojo T; Nagashima A; Moritomo A; Imai K; Miyake H
Bioorg Med Chem; 2013 May; 21(9):2478-94. PubMed ID: 23540955
[TBL] [Abstract][Full Text] [Related]
16. Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.
Istyastono EP; Nijmeijer S; Lim HD; van de Stolpe A; Roumen L; Kooistra AJ; Vischer HF; de Esch IJ; Leurs R; de Graaf C
J Med Chem; 2011 Dec; 54(23):8136-47. PubMed ID: 22003888
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema.
Inoue T; Morita M; Tojo T; Yoshihara K; Nagashima A; Moritomo A; Ohkubo M; Miyake H
Bioorg Med Chem; 2013 Mar; 21(5):1219-33. PubMed ID: 23337801
[TBL] [Abstract][Full Text] [Related]
18. Exploring the binding mode of semicarbazide-sensitive amine oxidase/VAP-1: identification of novel substrates with insulin-like activity.
Marti L; Abella A; De La Cruz X; García-Vicente S; Unzeta M; Carpéné C; Palacín M; Testar X; Orozco M; Zorzano A
J Med Chem; 2004 Sep; 47(20):4865-74. PubMed ID: 15369390
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effects of LJP 1586 [Z-3-fluoro-2-(4-methoxybenzyl)allylamine hydrochloride], an amine-based inhibitor of semicarbazide-sensitive amine oxidase activity.
O'Rourke AM; Wang EY; Miller A; Podar EM; Scheyhing K; Huang L; Kessler C; Gao H; Ton-Nu HT; Macdonald MT; Jones DS; Linnik MD
J Pharmacol Exp Ther; 2008 Feb; 324(2):867-75. PubMed ID: 17993604
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrates located on the top of the "cap" contribute to the adhesive and enzymatic functions of vascular adhesion protein-1.
Maula SM; Salminen T; Kaitaniemi S; Nymalm Y; Smith DJ; Jalkanen S
Eur J Immunol; 2005 Sep; 35(9):2718-27. PubMed ID: 16082728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
